Fintepla 2.2 mg/mL oral solution Images
Generic Name: fenfluramine
This medication has been identified as Fintepla 2.2 mg/mL oral solution. It is supplied by Zogenix, Inc.
Fintepla is used in the treatment of Dravet Syndrome; Lennox-Gastaut Syndrome and belongs to the drug classes CNS stimulants, miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Fintepla 2.2 mg/mL oral solution is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Fintepla
- Generic Name
- fenfluramine
- Strength
- 2.2 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- CNS stimulants, Miscellaneous anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Zogenix, Inc.
- National Drug Code (NDC)
- 43376-0322
More about Fintepla (fenfluramine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
